The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Prevalence and Patterns of Use of Psychoactive Medicines Among Individuals with Autism in the Autism Society of Ohio
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Risperidone in Children with Autism and Serious Behavioral Problems
McCracken, J. T., McGough, J., Shah, B., Cronin, P., Hong, D., Aman, M. G., Arnold, L. E., Lindsay, R., Nash, P., Hollway, J., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013171 · Cited by 1,574
Self-citation
Cited by
Management of Children With Autism Spectrum Disorders
Myers, S. M., Johnson, C. P., & the Council on Children With Disabilities (2007) · Pediatrics · doi:10.1542/peds.2007-2362 · Cited by 1,125
Lam, K. S. L., & Aman, M. G. (2007) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-006-0213-z · Cited by 793
Self-citationTaylor, J. L., & Seltzer, M. M. (2011) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-010-1070-3 · Cited by 735
The Lifetime Distribution of the Incremental Societal Costs of Autism
Ganz, M. L. (2007) · Archives of Pediatrics & Adolescent Medicine · doi:10.1001/archpedi.161.4.343 · Cited by 621
Trajectory of development in adolescents and adults with autism
Seltzer, M. M., Shattuck, P., Abbeduto, L., & Greenberg, J. S. (2004) · Mental Retardation and Developmental Disabilities Research Reviews · doi:10.1002/mrdd.20038 · Cited by 588
Lecavalier, L. (2006) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-006-0147-5 · Cited by 569
Shattuck, P. T., Seltzer, M. M., Greenberg, J. S., Orsmond, G. I., Bolt, D., Kring, S., Lounds, J., & Lord, C. (2007) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-006-0307-7 · Cited by 558
Elevated cytokine levels in children with autism spectrum disorder
Molloy, C. A., Morrow, A. L., Meinzen-Derr, J., Schleifer, K., Dienger, K., Manning-Courtney, P., Altaye, M., & Wills-Karp, M. (2006) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2005.11.007 · Cited by 386
“Because an estimated 46% of children with ASD are treated with a pychotropic medication to control some of the symptoms of their disease (Aman et al., 2003), to exclude those children would have created a potentially biased sample.”
BackgroundGadow, K. D., Devincent, C. J., Pomeroy, J., & Azizian, A. (2005) · Autism · doi:10.1177/1362361305056079 · Cited by 388
A Systematic Review of Medical Treatments for Children With Autism Spectrum Disorders
McPheeters, M. L., Warren, Z., Sathe, N., Bruzek, J. L., Krishnaswami, S., Jerome, R. N., & Veenstra-VanderWeele, J. (2011) · Pediatrics · doi:10.1542/peds.2011-0427 · Cited by 356
Sleep Disturbances and Correlates of Children with Autism Spectrum Disorders
Liu, X., Hubbard, J. A., Fabes, R. A., & Adam, J. B. (2006) · Child Psychiatry and Human Development · doi:10.1007/s10578-006-0028-3 · Cited by 358
Neurochemical correlates of autistic disorder: a review of the literature
Lam, K. S. L., Aman, M. G., & Arnold, L. E. (2006) · Research in Developmental Disabilities · doi:10.1016/j.ridd.2005.03.003 · Cited by 318
Self-citationPsychotropic medication use among Medicaid-enrolled children with autism spectrum disorders
Mandell, D. S., Morales, K. H., Marcus, S. C., Stahmer, A. C., Doshi, J., & Polsky, D. E. (2008) · Pediatrics · doi:10.1542/peds.2007-0984 · Cited by 295
Changes in the Autism Behavioral Phenotype During the Transition to Adulthood
Taylor, J. L., & Seltzer, M. M. (2010) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-010-1005-z · Cited by 289
Use of psychotropic drugs in patients with autism spectrum disorders: a systematic review
Jobski, K., Höfer, J., Hoffmann, F., & Bachmann, C. (2017) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12644 · Cited by 263
Medication use among children with autism spectrum disorders
Oswald, D. P., & Sonenklar, N. A. (2007) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2006.17303 · Cited by 195
Use of psychotropic medication in children and adolescents with autism spectrum disorders
Coury, D. L., Anagnostou, E., Manning-Courtney, P., Reynolds, A., Cole, L., McCoy, R., Whitaker, A., & Perrin, J. M. (2012) · PEDIATRICS · doi:10.1542/peds.2012-0900d · Cited by 191
“,3 y (367) 2 (1) 0 0 1 1 0 0 3–5 y (1147) 119 (10) 23 (2) 10 (1) 39 (3) 54 (4) 17 (1.”
BackgroundMedication Patterns in Patients with Autism: Temporal, Regional, and Demographic Influences
Aman, M. G., Lam, K. S. L., & Van Bourgondien, M. E. (2005) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2005.15.116 · Cited by 174
Self-citationLangworthy-Lam, K. S., Aman, M. G., & Van Bourgondien, M. E. (2002) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/104454602762599853 · Cited by 123
Self-citationReddihough, D. S., Marraffa, C., Mouti, A., O’Sullivan, M., Lee, K. J., Orsini, F., Hazell, P., Granich, J., Whitehouse, A. J. O., Wray, J., et al. (2019) · JAMA · doi:10.1001/jama.2019.14685 · Cited by 99
Psychopharmacology in autism: an update
Canitano, R., & Scandurra, V. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.10.015 · Cited by 79
Melatonin in children with autistic spectrum disorders: recent and practical data
Doyen, C., Mighiu, D., Kaye, K., Colineaux, C., Beaumanoir, C., Mouraeff, Y., Rieu, C., Paubel, P., & Contejean, Y. (2011) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-011-0162-8 · Cited by 54
“children with autism and melatonin is reported to be used by 11% of children with autism [1, 11].”
BackgroundMoore, T. R., & Symons, F. J. (2009) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-009-0729-0 · Cited by 53
Metadata
- Authors
- Aman, M. G., Lam, K. S. L., & Collier-Crespin, A.
- Venue
- Journal of Autism and Developmental Disorders
- Published
- 2003-10
- Volume
- 33
- Issue
- 5
- Pages
- 527-534
- ISSN
- 0162-3257 (ISSN-L)
- 1573-3432
- OpenAlex
- W340753846
- Cited by
- 163
- References
- 1
- FWCI
- 3.56
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.